Advisory Committee on Immunization Practices (ACIP)

Register for upcoming October ACIP meeting

October 24-25, 2018

Deadline for registration:
Non-US Citizens: September 26, 2018
US Citizens: October 10, 2018

Registration is NOT required to watch the live meeting webcast or to listen via telephone.

Live Webcast Instructions

Public Comment Instructions [1 page]

• Recommendations
  Complete list of ACIP recommendations published in the MMWR.
• Immunization Schedules
  Links to the childhood, adolescent, catch-up, and adult immunization schedules; plus vaccine recording and screening forms.
• GRADE (Grading of Recommendations Assessment, Development & Evaluation)
  Find tables referenced in ACIP recommendations published in MMWR and learn about GRADE.

• Charter
  Defines ACIP's purpose, authority, and function; its structure, meetings, and compensation; plus costs, reports, and termination.
• Members
  Membership roster, including chair, executive secretary, voting members, ex officio members, and liaison representatives.
  • Nominations for future vacancies on ACIP
    Procedure for nomination of candidates for ACIP membership.
• Articles
  Journal articles about the ACIP.

• ACIP Guidance for Economics Studies
  Procedures for review of economic analyses to be presented to the ACIP.
• ACIP Guidance for Vaccine Recommendations for Pregnant & Breastfeeding Women
  Guiding principles for development of ACIP recommendations for vaccination of pregnant and breastfeeding women.
• ACIP Vaccine Acronyms

This ACIP flyer [2 pages] answers questions such as what does the ACIP consider in the vaccine recommendation process, including recommended ages for administration of various vaccines to children?

ACIP approved the following recommendations by majority vote at its June 2018 meeting:

• Reaffirmed the seasonal influenza recommendations for the 2018-2019 influenza season
• Anthrax vaccine use for post-exposure prophylaxis in a mass vaccination campaign, including:
  • The intramuscular route of administration may be used if the subcutaneous route of administration presents clinical, operational, or logistical challenges that may delay or prevent effective vaccination
  • Should there be an inadequate supply of anthrax vaccine available for post-exposure prophylaxis, either 2 full doses or 3 half doses of anthrax vaccine absorbed (AVA) may be used to expand vaccine coverage
  • In immunocompetent adults aged 18 through 65 years, antimicrobials given in conjunction with vaccine may be discontinued at 42 days after the first vaccine dose or 2 weeks after the last vaccine dose, whichever comes later

These recommendations have been adopted by the CDC Director and will become official once published in MMWR.

• Meeting Information Recent ACIP meeting agendas, detailed meeting minutes, live meetings, and presentation slides.
• Upcoming Meetings List of scheduled ACIP meeting dates.
• Register for a Meeting Next meeting's registration details including deadline, driving directions and hotel choices.